Literature DB >> 20345734

Emerging role for TNF-α in erectile dysfunction.

Fernando S Carneiro1, Robert Clinton Webb, Rita C Tostes.   

Abstract

INTRODUCTION: A role for cytokines in the pathophysiology of erectile dysfunction (ED) has emerged. Cytokines induce genes that synthesize other peptides in the cytokine family and several mediators, such as prostanoids, leukotrienes, nitric oxide, bradykinin, reactive oxygen species, and platelet-activating factor, all of which can affect vascular function. Consistent with the fact that the cavernosal tissue is a complex extension of the vasculature, risk factors that affect the vasculature have been shown to affect cavernosal function as well. Accordingly, the penile tissue has been recognized as an early sentinel for atherosclerosis that underlies coronary artery disease and cardiovascular diseases (CVD). AIM: To review the literature pertaining to the role of tumor necrosis factor-alpha (TNF-α) in ED.
METHODS: PubMed search for pertinent publications on the role of cytokines, particularly TNF-α, in CVD and ED. MAIN OUTCOME MEASURES: Clinical and experimental evidence demonstrates that TNF-α may play a role in ED.
RESULTS: TNF-α has been shown to play an important role in CVD, mainly due to its direct effects on the vasculature. In addition, high levels of TNF-α were demonstrated in patients with ED. In this review, we present a short description of the physiology of erection and the cytokine network. We focus on vascular actions of TNF-α that support a role for this cytokine as a potential candidate in the pathophysiology of ED, particularly in the context of CVD. A brief overview of its discovery, mechanisms of synthesis, receptors, and its main actions on the systemic and penile vasculature is also presented.
CONCLUSIONS: Considering that ED results from a systemic arterial defect not only confined to the penile vasculature, implication of TNF-α in the pathophysiology of ED offers a humoral linking between CVD and ED.
© 2010 International Society for Sexual Medicine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20345734      PMCID: PMC3031865          DOI: 10.1111/j.1743-6109.2010.01762.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  138 in total

Review 1.  Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease?

Authors:  M E Sullivan; C S Thompson; M R Dashwood; M A Khan; J Y Jeremy; R J Morgan; D P Mikhailidis
Journal:  Cardiovasc Res       Date:  1999-08-15       Impact factor: 10.787

2.  Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II.

Authors:  Haruhiko Ohtsu; Mizuo Mifune; Gerald D Frank; Shuichi Saito; Tadashi Inagami; Shokei Kim-Mitsuyama; Yoh Takuwa; Terukatsu Sasaki; Jeffrey D Rothstein; Hiroyuki Suzuki; Hidekatsu Nakashima; Elethia A Woolfolk; Evangeline D Motley; Satoru Eguchi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-06-30       Impact factor: 8.311

3.  Immunohistochemical localization of peripheral nitric oxide synthase-containing nerves using antibodies raised against synthesized C- and N-terminal fragments of a cloned enzyme from rat brain.

Authors:  P Alm; B Larsson; E Ekblad; F Sundler; K E Andersson
Journal:  Acta Physiol Scand       Date:  1993-08

Review 4.  Role of nitric oxide in the physiology of erection.

Authors:  A L Burnett
Journal:  Biol Reprod       Date:  1995-03       Impact factor: 4.285

5.  Interleukin-1 and interleukin-6 mediated skeletal muscle arteriolar vasodilation: in vitro versus in vivo studies.

Authors:  A Minghini; L D Britt; M A Hill
Journal:  Shock       Date:  1998-03       Impact factor: 3.454

6.  The temporal relationship between erectile dysfunction and cardiovascular disease.

Authors:  L D Hodges; M Kirby; J Solanki; J O'Donnell; D A Brodie
Journal:  Int J Clin Pract       Date:  2007-12       Impact factor: 2.503

7.  TNF alpha receptor expression in rat cardiac myocytes: TNF alpha inhibition of L-type Ca2+ current and Ca2+ transients.

Authors:  K A Krown; K Yasui; M J Brooker; A E Dubin; C Nguyen; G L Harris; P M McDonough; C C Glembotski; P T Palade; R A Sabbadini
Journal:  FEBS Lett       Date:  1995-11-27       Impact factor: 4.124

Review 8.  Cytokine signaling modules in inflammatory responses.

Authors:  John J O'Shea; Peter J Murray
Journal:  Immunity       Date:  2008-04       Impact factor: 31.745

9.  Sexual dysfunction among patients with arthritis.

Authors:  D J Blake; R Maisiak; A Koplan; G S Alarcón; S Brown
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

10.  Tumor necrosis factor-alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells.

Authors:  Hope D I Anderson; Dolkun Rahmutula; David G Gardner
Journal:  J Biol Chem       Date:  2003-10-27       Impact factor: 5.157

View more
  24 in total

1.  Long-term phosphodiesterase 5 inhibitor administration reduces inflammatory markers and heat-shock proteins in cavernous tissue of Zucker diabetic fatty rat (ZDF/fa/fa).

Authors:  J E Toblli; G Cao; M Angerosa; M Rivero
Journal:  Int J Impot Res       Date:  2015-07-23       Impact factor: 2.896

2.  Priapism after tumor necrosis factor alpha inhibitor use.

Authors:  Adam J Kreitenberg; Elizabeth C Ortiz; Daniel G Arkfeld
Journal:  Clin Rheumatol       Date:  2015-01-13       Impact factor: 2.980

Review 3.  aMMP-8 Oral Fluid PoC Test in Relation to Oral and Systemic Diseases.

Authors:  Timo Sorsa; Solomon Olusegun Nwhator; Dimitra Sakellari; Andreas Grigoriadis; Kehinde Adesola Umeizudike; Ella Brandt; Mutlu Keskin; Taina Tervahartiala; Pirjo Pärnänen; Shipra Gupta; Ritin Mohindra; Nagihan Bostanci; Nurcan Buduneli; Ismo Tapani Räisänen
Journal:  Front Oral Health       Date:  2022-06-10

Review 4.  Erectile dysfunction and diabetes: A melting pot of circumstances and treatments.

Authors:  Giuseppe Defeudis; Rossella Mazzilli; Marta Tenuta; Giovanni Rossini; Virginia Zamponi; Soraya Olana; Antongiulio Faggiano; Paolo Pozzilli; Andrea M Isidori; Daniele Gianfrilli
Journal:  Diabetes Metab Res Rev       Date:  2021-09-21       Impact factor: 8.128

5.  Vitamin D deficiency is independently associated with greater prevalence of erectile dysfunction: The National Health and Nutrition Examination Survey (NHANES) 2001-2004.

Authors:  Youssef M K Farag; Eliseo Guallar; Di Zhao; Rita R Kalyani; Michael J Blaha; David I Feldman; Seth S Martin; Pamela L Lutsey; Kevin L Billups; Erin D Michos
Journal:  Atherosclerosis       Date:  2016-07-29       Impact factor: 5.162

6.  Non-steroidal anti-inflammatory drug (NSAID) use is not associated with erectile dysfunction risk: results from the Prostate Cancer Prevention Trial.

Authors:  Darshan P Patel; Jeannette M Schenk; Amy Darke; Jeremy B Myers; William O Brant; James M Hotaling
Journal:  BJU Int       Date:  2015-09-20       Impact factor: 5.588

7.  Macrophage-Specific Toll Like Receptor 9 (TLR9) Causes Corpus Cavernosum Dysfunction in Mice Fed a High Fat Diet.

Authors:  Fernanda Priviero; Fabiano Calmasini; Vanessa Dela Justina; Camilla F Wenceslau; Cameron G McCarthy; R Clinton Webb
Journal:  J Sex Med       Date:  2021-03-16       Impact factor: 3.802

8.  Interactions between inflammation and female sexual desire and arousal function.

Authors:  Tierney K Lorenz
Journal:  Curr Sex Health Rep       Date:  2019-10-28

9.  Increased cavernosal relaxation by Phoneutria nigriventer toxin, PnTx2-6, via activation at NO/cGMP signaling.

Authors:  K P Nunes; B M Wynne; M N Cordeiro; M H Borges; M Richardson; R Leite; M E DeLima; R C Webb
Journal:  Int J Impot Res       Date:  2011-10-06       Impact factor: 2.896

10.  Does vitamin D deficiency contribute to erectile dysfunction?

Authors:  Marc Sorenson; William B Grant
Journal:  Dermatoendocrinol       Date:  2012-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.